Clinical trials: Survival, Prosthesis
Prosthesis Survival
A Phase III Study of Nimotuzumab Plus Concurrent Chemoradiotherapy in Loco-regional Esophageal Squamous Cell Carcinoma
Esophageal cancer is the sixth leading cause of cancer death in worldwide. Over the past 2 decades, well-designed clinical trials have documented the clinical benefits of combination of chemotherapy and radiation for localized…
- Trial name
- NCT02409186
- Testing
- Nimotuzumab, radiotherapy, chemoradiotherapy Paclitaxel
- Where
- 14 sites in China
- Volunteers
- 200 people
- Sponsor
- Shandong Cancer Hospital and Institute